Physician profile
Daniel S Ikeda
NPI 1164751947
$4,205.42
in general payments reported to CMS, 2019-2025
9 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.16 · 2022: $43.85 · 2024: $3,711 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,576 · Food and Beverage: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,575.50 |
| Food and Beverage | $545.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,939.07 | 2024 | Other - Miscellaneous |
| Globus Medical, INC. | $510.78 | 2024 | |
| Depuy Synthes Sales INC. | $368.07 | 2024-2025 | Embotrap, Trufill, Teligen |
| Contego Medical, INC | $148.89 | 2025 | |
| Ebi, LLC | $65.91 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Biocomposites INC | $58.97 | 2025 | Stimulan |
| Nuvasive, INC. | $52.57 | 2021-2022 | |
| Baxter Healthcare | $31.44 | 2022 | |
| Innovation Technologies INC | $29.72 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ikeda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.